期刊文献+

上海地区老年人肌少症骨骼肌质量诊断标准建立和流行病学调查 被引量:28

Establishment of muscle mass diagnostic standard of sarcopenia using a bioelectrical impedance analysis and epidemioiogical investigation of the elderly in Shanghai
原文传递
导出
摘要 目的应用生物电阻抗法(BIA)建立上海地区老年人肌少症骨骼肌质量诊断标准并开展上海地区老年人肌少症患病率的调查。方法对40例志愿者(年龄20~77岁)进行BIA和双能X线吸收仪(DEXA)检测,验证BIA测定瘦体组织的可靠性。对219例(年龄20440岁)健康青年人(男:女为100:119)进行BIA检测,获得峰值肌量和老年人肌少症诊断切点。对657例≥60岁医院体检和社区老年人(男:女为318:339)进行BIA检测,了解上海地区老年人肌少症患病率。结果BIA和DEXA检测瘦体组织差异无统计学意义(P=0.307)。健康青年人四肢肌肉组织和身高平方的比值(ASM/身高2)男性和女性分别为(7.90±0.62)kg/m2和(6.12±0.44)kg/m2,老年人肌少症诊断标准男性和女性分别为≤6.66kg/m2和≤5.24kg/m2。将老年人分为3个年龄段,60~岁、70~岁和≥80岁3个年龄段男性肌少症的患病率分别为14.6%、25.0%和36.0%,女性分别为6.8%、12.6Vo和27.9%。老年男性整体患病率为23.6%,女性为11.8%。结论BIA检测人体肌肉组织是可靠的,且随增龄肌少症患病率明显上升,男性高于女性。 Objective To establish diagnostic standard of sarcopenia using bioelectrical impedance analysis (BIA) and to obtain the prevalence of sarcopenia in the elderly in Shanghai. Methods 40 volunteers aged 20 77 years were enrolled and received BIA and dual-energy X-ray absorptiometry (DEXA) measurements in order to verify the reliability of BIA for measuring lean mass. 219 healthy young volunteers aged 20 to 40 years with ratio of gender men: women 100:119 had BIA measurements to obtain peak muscle mass and sarcopenia diagnostic cut-off point of the elderly. 657 elderly aged ~ 60 years with ratio of gendermen:women 318:339 took BIA measurements to obtain the prevalence of sarcopenia in the elderly in Shanghai. Results No statistical difference between BIA-measured and DEXA-measured LM was observed (P = 0. 307). The appendicular skeletal muscle mass/height2 (ASM/h2) was (7.90±0.62) kg/m2 in young men, and (6.12±0.44) kg/m2 in young women, the cut off in elderly men and women were ≤6.66 kg/m2 and ≤ 5.24 kg/m2 respectively. Elderly people were divided into three age groups: aged60-69 years group, aged 70-69 years group, aged ≥80 years group, The prevalence of sarcopenia were 14.6%, 25.0% and 36.0% in men and 6.8%, 12.6% and 27.9% in women in aged 60-69 years, aged 70-69 years, aged ≥ 80 years groups, respectively. The overall prevalence in elderly men and women were 23.6% and 11.8% respectively. Conclusions Measurement of LM by BIA is validated in Shanghai volunteers. The prevalence of sarcopenia in the elderly is increased with age, which is higher in elderly men than in elderly women.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2015年第5期483-486,共4页 Chinese Journal of Geriatrics
基金 达能膳食营养与宣教基金资助项目(DIC2012-07)
关键词 肌疾病 电阻抗 身体成分 Muscular diseases Electric impedance Body composition
  • 相关文献

参考文献20

  • 1Rosenberg IH. Sarcopenia: origins and clinical relevance EJ~. J Nutr, 1997,127 SupplS:S990 991.
  • 2Xu J, Knutson MD, Carter CS, et al. Iron accumulation with age, oxidative stress and functional decline ~ J ~ . PLoS One, 2008, 3: 2865-2867.
  • 3Robinson SM, Jameson KA, Batelaan SF, et al. Diet and its relationship with grip strength in community- dwelling older men and women: the Hertfordshire Cohort Study~J~. J Am Geriatr Soc,2008,56:84-90.
  • 4Abate M, Di Iorio A, Di Renzo D, et al. Frailty in the elderly: the physical dimension E J ] ~ Eura Medicophys, 2007, 43:407-415.
  • 5Symons TB, Schutzler SE, Cocke TL, et al. Aging does not impair the anabolic response to a protein-rich meal~J]. AmJ ClinNutr, 2007,86:451-456.
  • 6Janssen I, Shepard DS, Katzmarzyk PT, et al. The healthcare costs of sareopenia in the United States EJ~. J AmGeriatr Soc,2004,52:80 85.
  • 7郝秋奎,董碧蓉.老年人衰弱综合征的国际研究现状[J].中华老年医学杂志,2013,32(6):685-688. 被引量:61
  • 8CruzJentoftAJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis[J]. Age Ageing, 2010, 39: 412-423.
  • 9Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico[J]. Am J Epidemiol, 1998,147: 755-763.
  • 10陈敏,林轶凡,孙建琴,李臻,肖菲,华莉,李士捷.老年人随年龄增加肌肉衰减变化特点研究[J].肠外与肠内营养,2012,19(5):263-266. 被引量:35

二级参考文献13

  • 1Rosenberg IH. Sarcopenia : origins and clinical relevance. J Nutr,1997,127(Suppl) :S990-S991.
  • 2Baumgartner RN,Koehler KM,Gallagher D,et al. Epidemiology ofSarcopenia among the Elderly in New Mexico. Am J Epidemiolo-gy,1998,14(8) :755-763.
  • 3Waters DL,Baumgartner RN,Garry PJ, et al. Advangages of dieta-ry ,exercise-related,and therapeutic interventions to prevent andtreat sarcopenia in adult patients : an update. Clin Interv Aging,2010,5:259-270.
  • 4Janssen I,Shepard DS,Katzmarzyk PT,et al. The healthcare costsof sarcopenia in the United States. J Am Geriatr Soc, 2004, 52(1) :80-85.
  • 5Cruz-Jentoft AJ,Baeyens JP,Bauer JM,et al. Sarcopenia:Europe-an consensus on definition and diagnosis. Age Ageing,2010,39(4):412-423.
  • 6Lukaski HC,Johnson PE,Bolonchuk WW, et al. Assessment of fatfree mass using bioelectrical impedance measurements of the hu-man body. Am J Clin Nutr,1985 ,41 (4) :810-817.
  • 7Roubenoff R. Sarcopenia ? a major modifiable cause of frailty in theelderly. J Nutr Health Aging,2000,4(3) :140-142.
  • 8Forbes GB. Longitudinal changes in adult fat-free mass:influenceof body weight. Am J Clin Nutr,1999 ,70(6) : 1025-1031.
  • 9Cesari M, Kritchevsky SB, Baumgartner RN,et al. Sarcopenia,o-besity, and inflammation-results from the trial of angiotensin con-verting enzyme inhibition and novel cardiovascular risk factorsstudy. Am J Clin Nutr,2005 ,82(2) :428434.
  • 10Despr6s JP, Lemieux I, Bergeron J, et al. Abdominal obesity andthe metabolic syndrome : contribution to global cardio metabolicrisk. Arteriosclerosis, Thrombosis, and Vascular Biology ,2008,28(6) :1039-1049.

共引文献94

同被引文献156

引证文献28

二级引证文献197

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部